KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Accounts Payables (2016 - 2026)

Biogen has reported Accounts Payables over the past 18 years, most recently at $358.5 million for Q1 2026.

  • For Q1 2026, Accounts Payables fell 8.43% year-over-year to $358.5 million; the TTM value through Mar 2026 reached $358.5 million, down 8.43%, while the annual FY2025 figure was $432.0 million, 1.84% up from the prior year.
  • Accounts Payables for Q1 2026 was $358.5 million at Biogen, down from $432.0 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $491.5 million in Q4 2022 and troughed at $354.5 million in Q2 2024.
  • A 5-year average of $416.5 million and a median of $413.1 million in 2025 define the central range for Accounts Payables.
  • Biggest five-year swings in Accounts Payables: increased 23.2% in 2023 and later dropped 21.21% in 2024.
  • Year by year, Accounts Payables stood at $491.5 million in 2022, then decreased by 17.95% to $403.3 million in 2023, then rose by 5.18% to $424.2 million in 2024, then rose by 1.84% to $432.0 million in 2025, then fell by 17.01% to $358.5 million in 2026.
  • Business Quant data shows Accounts Payables for BIIB at $358.5 million in Q1 2026, $432.0 million in Q4 2025, and $413.1 million in Q3 2025.